PD61-11 A PHASE II STUDY OF 6-MONTHS APALUTAMIDE PRIOR TO RADICAL PROSTATECTOMY IN INTERMEDIATE RISK PATIENTS TO REDUCE THE FREQUENCY OF PATHOLOGIC FEATURES THAT DRIVE POST-OPERATIVE RADIATION THERAPY
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.